Leprosy diagnosed by bone marrow aspiration
Phagocytic blasts in B-lineage acute lymphoblastic leukaemia
Anti-tumour immunotherapy with Vγ9Vδ2 T lymphocytes: from the bench to the bedside
New ways to separate Graft- versus -Host Disease and Graft- versus -Tumour effects after allogeneic haematopoietic stem cell transplantation
Haematopoietic stem cell transplantation for SCID patients: where do we stand?
Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition)
Response assessment in Waldenström macroglobulinaemia: update from the VIth International Workshop
JAK2-V617F-mediated signalling is dependent on lipid rafts and statins inhibit JAK2-V617F-dependent cell growth
Prognostic and therapeutic relevance of c-FLIP in acute myeloid leukaemia
Late relapses following reduced intensity allogeneic transplantation in patients with multiple myeloma: a long-term follow-up study
Efficacy and safety of bendamustine for the treatment of patients with recurring Hodgkin lymphoma
Comparative analysis of IL6 and IL6 receptor gene polymorphisms in mastocytosis
Clinical phenotype, laboratory features and genotype of 35 patients with heritable dysfibrinogenaemia
Combination of recombinant factor VIIa and fibrinogen corrects clot formation in primary immune thrombocytopenia at very low platelet counts
The beta 1 tubulin R307H single nucleotide polymorphism is associated with treatment failures in immune thrombocytopenia (ITP)
Autoantibodies to erythropoietin receptor in patients with immune-mediated diseases: relationship to anaemia with erythroid hypoplasia
Leucocytosis and thrombosis at diagnosis are associated with poor survival in polycythaemia vera: a population-based study of 327 patients
Rapid T-cell chimerism switch and memory T-cell expansion are associated with pre-engraftment immune reaction early after cord blood transplantation
Combined blood transfusion and hydroxycarbamide in children with sickle cell anaemia
Expression of CD25 independently predicts early treatment failure of acute myeloid leukaemia (AML)
Improved outcome of adults with aplastic anaemia treated with arsenic trioxide plus ciclosporin
The BCL2L11 ( BIM ) deletion polymorphism is a possible criterion for discontinuation of imatinib in chronic myeloid leukaemia patients